Nadi Tarangini to Transform Ayurveda with CDSCO Approval
Jan 7, 2025
Source: Times of India
Share:
Nadi Tarangini, India's first Ayurvedic diagnostic tool approved by CDSCO, is going to transform healthcare by amalgamating the ancient wisdom of Ayurveda with modern technology.
Key Highlights
Scientific Innovation Meets Ayurveda:
Developed by well-known chemical-nuclear scientist J.B. Joshi along with his son, Aniruddha Joshi, Nadi Tarangini, uses very advanced sensors and artificial intelligence to analyze vata, pitta, and kapha–those fundamental principles that lie at the very basis of diagnosing Ayurveda.
A Vision 20 Years in the Making:
Inspired by this variation in pulse diagnosis in the Ayurvedic way of medicine during his treatment two decades back, J.B. Joshi envisioned a scientific approach toward standardization. His son, who is a PhD scholar in IIT Bombay, designed piezoelectric sensors mimicking the human sensitivity of fingertips to measure pulse waves precisely.
Technologically aided diagnosis:
The device gives a very detailed 10-page report in 10 Indian languages, for 22 Ayurvedic parameters including stress levels, digestive health, and general well-being. Data-driven insights help to make Ayurveda evidence-based and more credible worldwide.
CDSCO Approval Journey
Extensive Validation:
In the CDSCO certification process, data from 25,000 patients validated the accuracy of Nadi Tarangini at 85%.
Patents and Global Adoption:
Patents have been obtained in India, the US, Europe, and Indonesia. The device is being used in 1,250 Ayurvedic clinics and has tested over five lakh patients.
Support and Commercialization:
Aniruddha Joshi started Atreya Innovations in Pune with funding from CSIR and mentorship by Persistent Systems' Anand Deshpande to take the technology to the market.
Implications for Ayurveda
Standardization and Global Relevance:
With CDSCO certification, Nadi Tarangini is well placed to standardize Ayurvedic diagnostic practices, thereby enhancing their credibility and acceptance worldwide.
Bridging Ancient and Modern Healthcare:
By integrating AI and sensor technology, the device brings together traditional Ayurveda with modern medical standards, thereby making it more accessible and scientifically validated.Nadi Tarangini is a paradigm shift in Ayurvedic healthcare, offering a data-driven, standardized approach to diagnosis. With CDSCO approval and widespread adoption, it marks a significant step toward making Ayurveda a globally recognized, evidence-based medical practice.
Copyright © 2024 Pharmacy Pro. All rights reserved.
Copyright © 2024 Pharmacy Pro. All rights reserved.
Copyright © 2024 Pharmacy Pro. All rights reserved.
Source: Times of India
Nadi Tarangini, India's first Ayurvedic diagnostic tool approved by CDSCO, is going to transform healthcare by amalgamating the ancient wisdom of Ayurveda with modern technology.
Key Highlights
Scientific Innovation Meets Ayurveda:
Developed by well-known chemical-nuclear scientist J.B. Joshi along with his son, Aniruddha Joshi, Nadi Tarangini, uses very advanced sensors and artificial intelligence to analyze vata, pitta, and kapha–those fundamental principles that lie at the very basis of diagnosing Ayurveda.
A Vision 20 Years in the Making:
Inspired by this variation in pulse diagnosis in the Ayurvedic way of medicine during his treatment two decades back, J.B. Joshi envisioned a scientific approach toward standardization. His son, who is a PhD scholar in IIT Bombay, designed piezoelectric sensors mimicking the human sensitivity of fingertips to measure pulse waves precisely.
Technologically aided diagnosis:
The device gives a very detailed 10-page report in 10 Indian languages, for 22 Ayurvedic parameters including stress levels, digestive health, and general well-being. Data-driven insights help to make Ayurveda evidence-based and more credible worldwide.
CDSCO Approval Journey
Extensive Validation:
In the CDSCO certification process, data from 25,000 patients validated the accuracy of Nadi Tarangini at 85%.
Patents and Global Adoption:
Patents have been obtained in India, the US, Europe, and Indonesia. The device is being used in 1,250 Ayurvedic clinics and has tested over five lakh patients.
Support and Commercialization:
Aniruddha Joshi started Atreya Innovations in Pune with funding from CSIR and mentorship by Persistent Systems' Anand Deshpande to take the technology to the market.
Implications for Ayurveda
Standardization and Global Relevance:
With CDSCO certification, Nadi Tarangini is well placed to standardize Ayurvedic diagnostic practices, thereby enhancing their credibility and acceptance worldwide.
Bridging Ancient and Modern Healthcare:
By integrating AI and sensor technology, the device brings together traditional Ayurveda with modern medical standards, thereby making it more accessible and scientifically validated.Nadi Tarangini is a paradigm shift in Ayurvedic healthcare, offering a data-driven, standardized approach to diagnosis. With CDSCO approval and widespread adoption, it marks a significant step toward making Ayurveda a globally recognized, evidence-based medical practice.
Share:
Read Next
Read Next
Copyright © 2024 Pharmacy Pro. All rights reserved.
Copyright © 2024 Pharmacy Pro. All rights reserved.